Published Papers & Misc - UCHIDA Shinichi

Division display  41 - 60 of about 87 ／  All the affair displays >>

  1. Nanamatsu A, Mori T, Ando F, Furusho T, Mandai S, Susa K, Sohara E, Rai T, Uchida S. Vasopressin Induces Urinary Uromodulin Secretion By Activating PKA (Protein Kinase A). Hypertension. 2021.06; 77 (6): 1953-1963. ( PubMed, DOI )

  2. Shimohata H, Miyake Y, Yoshida Y, Usui J, Mori T, Sohara E, Uchida S, Hirayama K, Kobayashi M. LMX1B-associated nephropathy that showed myelin figures on electron microscopy. CEN case reports. 2021.06; 10 (4): 588-591. ( PubMed, DOI )

  3. Fujimaru T, Kawanishi K, Mori T, Mishima E, Sekine A, Chiga M, Mizui M, Sato N, Yanagita M, Ooki Y, Nagahama K, Ohnuki Y, Hamano N, Watanabe S, Mochizuki T, Nagatsuji K, Tanaka K, Tsukamoto T, Tsushima H, Shimamoto M, Tsuji T, Kuyama T, Kawamoto S, Maki K, Katsuma A, Oishi M, Yamamoto K, Mandai S, Kikuchi H, Ando F, Mori Y, Susa K, Iimori S, Naito S, Rai T, Hoshino J, Ubara Y, Miyazaki M, Nagata M, Uchida S, Sohara E. Genetic Background and Clinicopathologic Features of Adult-onset Nephronophthisis. Kidney international reports. 2021.05; 6 (5): 1346-1354. ( PubMed, DOI )

  4. Takahashi Naohiro, Kikuchi Hiroaki, Usui Ayaka, Furusho Taisuke, Fujimaru Takuya, Fujiki Tamami, Yanagi Tomoki, Matsuura Yoshiaki, Asano Kenichi, Yamamoto Kouhei, Ando Fumiaki, Susa Koichiro, Mandai Shintaro, Mori Takayasu, Rai Tatemitsu, Uchida Shinichi, Arita Makoto, Sohara Eisei. Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidney(和訳中) Clinical and Experimental Nephrology. 2021.05; 25 (5): 445-455. ( ichushi )

  5. Takahashi Naohiro, Kikuchi Hiroaki, Usui Ayaka, Furusho Taisuke, Fujimaru Takuya, Fujiki Tamami, Yanagi Tomoki, Matsuura Yoshiaki, Asano Kenichi, Yamamoto Kouhei, Ando Fumiaki, Susa Koichiro, Mandai Shintaro, Mori Takayasu, Rai Tatemitsu, Uchida Shinichi, Arita Makoto, Sohara Eisei. Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD(2) in the kidney CLINICAL AND EXPERIMENTAL NEPHROLOGY. 2021.05; 25 (5): 445-455. ( PubMed, DOI )

  6. Oe Y, Mishima E, Mori T, Okamoto K, Honkura Y, Nagasawa T, Yoshida M, Sato H, Suzuki J, Ikeda R, Sohara E, Uchida S, Katori Y, Miyazaki M. A Novel Mutation in LMX1B (p.Pro219Ala) Causes Focal Segmental Glomerulosclerosis with Alport Syndrome-like Phenotype. Internal medicine (Tokyo, Japan). 2021.04; 60 (18): 2991-2996. ( PubMed, DOI )

  7. Tao K, Awazu M, Honda M, Shibata H, Mori T, Uchida S, Hasegawa T, Ishii T. An infant with congenital nephrogenic diabetes insipidus presenting with hypercalcemia and hyperphosphatemia. Endocrinology, diabetes & metabolism case reports. 2021.04; 2021 ( PubMed, DOI )

  8. Mori T, Chiga M, Fujimaru T, Kawamoto R, Mandai S, Nanamatsu A, Nomura N, Ando F, Susa K, Sohara E, Rai T, Uchida S. Phenotypic differences of mutation-negative cases in Gitelman syndrome clinically diagnosed in adulthood. Hum Mutat. 2021.03; 42 (3): 300-309. ( PubMed, DOI )

  9. Hiroko Hashimoto, Satomi Shikuma, Shintaro Mandai, Susumu Adachi, Shinichi Uchida. Calcium-based phosphate binder use is associated with lower risk of osteoporosis in hemodialysis patients. Sci Rep. 2021.01; 11 (1): 1648. ( PubMed, DOI )

  10. Umene Ryusuke, Kitamura Mineaki, Arai Hideyuki, Matsumura Kazuki, Ishimaru Yuka, Maeda Kanenori, Uramatsu Tadashi, Obata Yoko, Mori Takayasu, Sohara Eisei, Uchida Shinichi, Nishino Tomoya. 腎機能障害により悪化した2遺伝子性の塩類喪失性尿細管機能異常症を呈したBartter症候群(Bartter syndrome representing digenic-based salt-losing tubulopathies presumably accelerated by renal insufficiency) CEN Case Reports. 2020.11; 9 (4): 375-379. ( ichushi )

  11. Furusho T, Uchida S, Sohara E. The WNK signaling pathway and salt-sensitive hypertension Hypertension Research. 2020.08; 43 (8): 733-743. ( ichushi )

  12. Shoda W, Nomura N, Ando F, Tagashira H, Iwamoto T, Ohta A, Isobe K, Mori T, Susa K, Sohara E, Rai T, Uchida S. Sodium-calcium exchanger 1 is the key molecule for urinary potassium excretion against acute hyperkalemia PLoS One. 2020.06; 15 (6): e0235360. ( PubMed, DOI )

  13. Furusho T, Sohara E, Mandai S, Kikuchi H, Takahashi N, Fujimaru T, Hashimoto H, Arai Y, Ando F, Zeniya M, Mori T, Susa K, Isobe K, Nomura N, Yamamoto K, Okado T, Rai T, Uchida S. Renal TNFα activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease. Kidney Int. 2020.02; 97 (4): 713-727. ( PubMed, DOI )

  14. Kikuchi Hiroaki, Sasaki Emi, Nomura Naohiro, Mori Takayasu, Minamishima Yoji Andrew, Yoshizaki Yuki, Takahashi Naohiro, Furusho Taisuke, Arai Yohei, Mandai Shintaro, Yamashita Takahiro, Ando Fumiaki, Maejima Yasuhiro, Isobe Kiyoshi, Okado Tomokazu, Rai Tatemitsu, Uchida Shinichi, Sohara Eisei. Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease Kidney Int.. 2019.01; 95 (1): 123-137. ( PubMed, DOI )

  15. Fujimaru T, Mori T, Sekine A, Mandai S, Chiga M, Kikuchi H, Ando F, Mori Y, Nomura N, Iimori S, Naito S, Okado T, Rai T, Hoshino J, Ubara Y, Uchida S, Sohara E. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease Clin Genet. 2018.07; 94 (1): 125-131. ( DOI )

  16. Ando F, Mori S, Yui N, Morimoto T, Nomura N, Sohara E, Rai T, Sasaki S, Kondo Y, Kagechika H, Uchida S. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus Nat Commun. 2018.04; 9 (1): 1411. ( PubMed, DOI )

  17. Sasaki E, Susa K, Mori T, Isobe K, Araki Y, Inoue Y, Yoshizaki Y, Ando F, Mori Y, Mandai S, Zeniya M, Takahashi D, Nomura N, Rai T, Uchida S, Sohara E. KLHL3 knockout mice reveal the physiological role of KLHL3 and the pathophysiology of pseudohypoaldosteronism type II caused by mutant KLHL3. Mol Cell Biol. 2017.04; 37 (7): ( PubMed, DOI )

  18. Takahashi D, Mori T, Sohara E, Tanaka M, Chiga M, Inoue Y, Nomura N, Zeniya M, Ochi H, Takeda S, Suganami T, Rai T, Uchida S. WNK4 is an adipogenic factor and its deletion reduces diet-induced obesity in mice. EBioMedicine. 2017.04; 18 118-127. ( PubMed, DOI )

  19. Nagata Soichiro, Ikegaya Naoki, Ogino Shuhei, Uchida Shinichi, Itaya Mikiko, Momita Aoi, Shinozaki Shingo, Ohura Masaharu, Kuriki Ken, Kono Satoshi, Miyajima Hiroaki, Hishida Akira. 無セルロプラスミン血症を呈する血液透析患者において甲状腺癌切除は赤血球産生刺激製剤への低反応性を改善する(The Resection of Thyroid Cancer Was Associated with the Resolution of Hyporesponsiveness to an Erythropoiesis-stimulating Agent in a Hemodialysis Patient with Aceruloplasminemia) Internal Medicine. 2017.04; 56 (7): 805-810. ( ichushi )

  20. Shoda W, Nomura N, Ando F, Mori Y, Mori T, Sohara E, Rai T, Uchida S. Calcineurin inhibitors block sodium-chloride cotransporter dephosphorylation in response to high potassium intake. Kidney Int. 2017.02; 91 (2): 402-411. ( PubMed, DOI )

< PREV - NEXT >

To the head of this page.▲